Frontlight ResearchEarly access
Trial site
Veterans Affairs Loma Linda Healthcare System
- 14running trials
- 4closed trials
The trials here
What the 20 trials at this site are about, from their registry records.
- Conditions
- Lung cancer10 trials
- Colorectal cancer5 trials
- Childhood cancers4 trials
- Melanoma4 trials
- Pancreatic cancer3 trials
- Prostate cancer3 trials
- Acute myeloid leukaemia2 trials
- Gastric and oesophageal cancer2 trials
- Metastatic breast cancer2 trials
- Multiple myeloma2 trials
- Ovarian cancer2 trials
- Acute lymphoblastic leukaemia1 trial
- and 5 more
- Phase
- Phase 39 trials
- Phase 23 trials
- Phase 2/32 trials
- Status
- Active, not recruiting8 trials
- Recruiting6 trials
- Completed4 trials
- Suspended2 trials
- Lead sponsor
- National Cancer Institute (NCI)7 trials
- SWOG Cancer Research Network7 trials
- Alliance for Clinical Trials in Oncology3 trials
- ECOG-ACRIN Cancer Research Group2 trials
- NRG Oncology1 trial
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Active, not recruiting
Active, not recruiting
Recruiting
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer3 recruiting
- Colorectal cancer2 recruiting
- Melanoma2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Acute myeloid leukaemia1 recruiting
- Bladder cancer1 recruiting
- Childhood cancers1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Kidney cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Multiple myeloma1 recruiting
- Ovarian cancer1 recruiting
- Pancreatic cancer1 recruiting
- Prostate cancer1 recruiting
Closed trials
Completed
Completed
Completed
S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer
Completed
Site data: ClinicalTrials.govUpdated 19 Nov 2026